Company
Headquarters: Tainan City, Taiwan
TW$2.01 Billion
TWD as of July 1, 2024
US$61.7 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Winston Medical Supply Co.,Ltd. engages in the development, manufacture, and distribution of pharmaceuticals, nutrition supplements, and cosmeceutical products. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations, which are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, and capsules for the treatment of colds, gastrointestinal issues, or other indications. The company was founded in 1974 and is based in Tainan City, Taiwan. As of January 2014, Winston Medical Supply Co., Ltd. operates as a subsidiary of Medigen Biotechnology Corp.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Winston Medical Supply Co.,Ltd has the following listings and related stock indices.
Stock: TWSE: 6817 wb_incandescent